Citations

Clear

6273 citation(s) found for "To, Andrew".

Distinct impacts of KRAS, NRAS and BRAF mutations on survival of patients with metastatic colorectal cancer.
Yu, Cecilia, Tschautscher, Marcella , Briggler, Andrew M., Overman, Michael J. , Broaddus, Russell R. , Balcom, Jessica R. , Kipp, Benjamin R. , Grothey, Axel, Wang, Yucai , Loree, Jonathan M. , Meric‐Bernstam, Funda , Jones, Jeremy C , Kopetz, Scott

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 3513-3513

10.1200/jco.2018.36.15_suppl.3513 Get It

Causal modeling of CALGB 80405 (Alliance) to identify network drivers of metastatic colorectal cancer (CRC).
Das, Rahul K, Innocenti, Federico , Cunha, Daniel Ferreira da , Rich, Kelly , Lenz, Heinz‐Josef , Niedzwiecki, Donna , Wuest, Diane, Hayete, Boris , Khalil, Iya, Niedzwiecki, Donna , Das, Rahul K, Furchtgott, Leon , Meyerhardt, Jeffrey A. , Nixon, Andrew B. , Cunha, Daniel, Rich, Kelly, O’Reilly, Eileen M. , Ou, Fang‐Shu , Latourelle, Jeanne C. , Venook, Alan P.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 3570-3570

10.1200/jco.2018.36.15_suppl.3570 Get It

TAPPAS: An adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma.
Ravi, Vinod , Chawla, Sant P. , Attia, Steven , Riedel, Richard F. , Thornton, Katherine A., Mallick, Atrayee Basu , Liu, Lingyun , Alvarez, Delia, Theuer, Charles P. , Tap, William D. , Jones, Robin L. , Maki, Robert G. , Maki, Robert G , Riedel, Richard F , Jones, Robin L , Brohl, Andrew S. , Liebner, David A. , Mehta, Cyrus R. , Robinson, Steven I. , Penel, Nicolas , Stacchiotti, Silvia

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS11590-TPS11590

10.1200/jco.2018.36.15_suppl.tps11590 Get It

Subgroup analysis of elderly patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial.
Younger, Eugenie , Pápai, Zsuzsanna , Tine, Brian Andrew Van, Attia, Steven , Lu, Yao , Schöffski, Patrick , Tap, William D. , Jones, Robin L. , Jones, Robin L , Ballman, Karla V. , Reinke, Denise K.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 11575-11575

10.1200/jco.2018.36.15_suppl.11575 Get It

A phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas.
Agulnik, Mark , Mohindra, Nisha , Attia, Steven , Rademaker, Alfred , Abbinanti, Susan, Cehic, Rasima, Humphreys, Catherine , Okuno, Scott H. , Tine, Brian Andrew Van, Milhem, Mohammed , Robinson, Steven I. , Humphreys, Catherine, Prudner, Bethany Cheree

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 11550-11550

10.1200/jco.2018.36.15_suppl.11550 Get It

Phase 1b/2 study of olaratumab plus gemcitabine and docetaxel for the treatment of advanced soft tissue sarcoma (STS) (ANNOUNCE 2): Phase 1b results.
Villalobos, Víctor M. , Tine, Brian Andrew Van, Dickson, Mark A. , Cronier, Damien M., Attia, Steven , Redondo, Andrés , Schwartz, Gary K. , Chmielowski, Bartosz , Peterson, Patrick M. , Wright, Jennifer

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 11542-11542

10.1200/jco.2018.36.15_suppl.11542 Get It

ADAM trial: A multicenter, randomized, double-blinded, placebo-controlled, phase 3 trial of adjuvant avelumab (anti-PD-L1 antibody) in merkel cell carcinoma patients with clinically detected lymph node metastases; NCT03271372.
Chandra, Sunandana , Dakhil, Sumia, Fecher, Leslie A. , Gooley, Ted , Hibbert, Reina, Kelly, Ciara M. , Kiriluk, Samantha M., Nghiem, Paul , Nguyen, Vivian , Pelz, Nichole Real, Poisson, Aubrey A., Price, Katharine A. , Sondak, Vernon K. , Thompson, John A. , Bhatia, Shailender , Brohl, Andrew S. , Brownell, Isaac , Ernstoff, Marc S. , Hanna, Glenn J. , Tykodi, Scott S.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS9605-TPS9605

10.1200/jco.2018.36.15_suppl.tps9605 Get It

Assessment of activating estrogen receptor 1 (ESR1) mutations in gynecologic malignancies.
Gay, Laurie M. , Steiner, M., Andreano, Kaitlyn J., Davidson, Brittany A. , Colón‐Otero, Gerardo , Zajchowski, Deborah A., McDonnell, Donald P. , Elvin, Julia A. , Gaillard, Stéphanie , Havrilesky, Laura Jean , Secord, Angeles Alvarez , Valea, Fidel A. , Chang, Ching‐yi , Berchuck, Andrew , Elvin, Julia A

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5590-5590

10.1200/jco.2018.36.15_suppl.5590 Get It

A phase 1/2, open-label dose-escalation study of liposomal irinotecan (nal-IRI) plus 5- fluorouracil/leucovorin (5-FU/LV) and oxaliplatin (OX) in patients with previously untreated metastatic pancreatic cancer (mPAC).
Dean, Andrew , Ramanathan, Ramesh K., Mody, Kabir , Belanger, Bruce , Jong, Floris A. de, Braun, Stephan , Wainberg, Zev A. , Boland, Patrick M. , Zhang, Bin

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 4111-4111

10.1200/jco.2018.36.15_suppl.4111 Get It